Active Biotech AB (publ) logo

Active Biotech AB (publ)

SSE:ACTI.ST

Overview | Financials
Company Name Active Biotech AB (publ)
Symbol ACTI.ST
Currency SEK
Price 0.685
Market Cap 259,210,850
Dividend Yield 0%
52-week-range 0.401 - 1.478
Industry Biotechnology
Sector Healthcare
CEO Ms. Helen Tuvesson Ph.D.
Website https://www.activebiotech.com

An error occurred while fetching data.

About Active Biotech AB (publ)

Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the

Related Stocks

ProstaLund AB (publ) logo

ProstaLund AB (publ)

PLUN.ST

1.575 SEK

Clinical Laserthermia Systems AB (publ) logo

Clinical Laserthermia Systems AB (publ)

CLS-B.ST

0.102 SEK

aXichem AB logo

aXichem AB

AXIC-A.ST

1.7 SEK

Magle Chemoswed Holding AB (publ) logo

Magle Chemoswed Holding AB (publ)

MAGLE.ST

27.6 SEK

AcouSort AB (publ) logo

AcouSort AB (publ)

ACOU.ST

13.2 SEK

Corline Biomedical AB logo

Corline Biomedical AB

CLBIO.ST

13.8 SEK

Ortivus AB (publ) logo

Ortivus AB (publ)

ORTI-B.ST

3.44 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD